-- 四環医薬（香港証券取引所：0460）の受託者は、2022年の株式付与制度に基づき、同社株300万株を1株あたり約1.3567香港ドルで市場から買い戻した。これは火曜日に香港証券取引所に提出された書類で明らかになった。 この買い戻し株数は、同社の発行済み株式資本の0.0328%に相当する。
Related Articles
Asia
Uni-President Enterprises Unit Buys Structured Deposit Worth 100 Million Yuan
Uni-President Enterprises (TPE:1216) unit China investment acquired a structured deposit product from CTBC Bank's Shanghai branch worth 100 million yuan, according to a Friday Taiwan Exchange filing.Shares gained about 1% in Monday's late morning trade.The product, named Hui Gao Xin Fu 20260028, is a principal-guaranteed, RMB-linked structured deposit.The investment is aimed at generating stable returns through low-risk financial products, the filing said.
$TPE:1216
Asia
Keppel Unit Starts Arbitration vs Vietnam JV Partners Over Land Use Fees
Keppel's (SGX:BN4) subsidiary, Corredance, started an arbitration against its three partners in a Vietnamese joint venture over land fees, according to a Monday filing with the Singapore Exchange.Corredance is seeking declarations that Denver Power, Tien Phuoc Real Estate Joint Stock Company, and Tran Thai Lands, not the company, are fully liable for about 6.877 trillion dong of additional land use fees that the authorities have imposed on their joint venture by the end of 2025.The joint venture was established for constructing, developing and operating residential and mixed-use developments in Ho Chi Minh. It is 40% owned by Corredance.
$SGX:BN4
Asia
China Resources Microelectronics' Q1 Profit Soars 297%, Revenue Jumps 21%
China Resources Microelectronics' (SHA:688396) net profit attributable to shareholders in the first quarter surged 297% to 330 million yuan from 83.2 million yuan a year earlier, according to a Shanghai bourse filing on Saturday.The Chinese semiconductor manufacturer's shares rose 1% during Monday's midday trade.Earnings per share soared 295% year on year to 0.25 yuan from 0.06 yuan.Operating revenue jumped 21% to 2.86 billion yuan from 2.35 billion yuan in the previous year.
$SHA:688396